Literature DB >> 16313906

Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells.

Tianhong Pan1, Xinqun Li, Wenjie Xie, Joseph Jankovic, Weidong Le.   

Abstract

Valproic acid (VPA), an anticonvulsant and mood-stabilizing drug, has been reported to exert neuroprotection against a variety of insults. We now show that VPA attenuates rotenone (a potent complex I inhibitor)-induced apoptosis through the induction of heat shock protein 70, which may interact with apoptotic-protease-activating factor 1. Activation of p-Akt, p-Bcl-2, as well as p-Erk1/2 by VPA may be co-contributors to the protection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16313906     DOI: 10.1016/j.febslet.2005.10.067

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  26 in total

Review 1.  Molecular chaperones in Parkinson's disease--present and future.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

Review 2.  Molecular chaperones and co-chaperones in Parkinson disease.

Authors:  Hemi Dimant; Darius Ebrahimi-Fakhari; Pamela J McLean
Journal:  Neuroscientist       Date:  2012-07-24       Impact factor: 7.519

3.  Role of MFHAS1 in regulating hepcidin expression via the BMP/SMAD and MAPK/ERK1/2 signalling pathways.

Authors:  Chutima Kumkhaek; Christian LaChance; Wulin Aerbajinai; Jianqiong Zhu; Griffin P Rodgers
Journal:  Br J Haematol       Date:  2019-05-02       Impact factor: 6.998

Review 4.  Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage.

Authors:  Brian Y Hwang; Geoffrey Appelboom; Amit Ayer; Christopher P Kellner; Ivan S Kotchetkov; Paul R Gigante; Raqeeb Haque; Michael Kellner; E Sander Connolly
Journal:  Cerebrovasc Dis       Date:  2010-12-21       Impact factor: 2.762

5.  Valproic acid activates the PI3K/Akt/mTOR pathway in muscle and ameliorates pathology in a mouse model of Duchenne muscular dystrophy.

Authors:  Praveen B Gurpur; Jianming Liu; Dean J Burkin; Stephen J Kaufman
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

6.  Effects of mood stabilizers on DNA damage in an animal model of mania.

Authors:  Ana Cristina Andreazza; Marcia Kauer-Sant'Anna; Benicio N Frey; Laura Stertz; Caroline Zanotto; Leticia Ribeiro; Karine Giasson; Samira S Valvassori; Gislaine Z Réus; Mirian Salvador; João Quevedo; Carlos A Gonçalves; Flavio Kapczinski
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

7.  Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS).

Authors:  Kennichi C Dowdell; Lesley Pesnicak; Victoria Hoffmann; Kenneth Steadman; Alan T Remaley; Jeffrey I Cohen; Stephen E Straus; V Koneti Rao
Journal:  Exp Hematol       Date:  2009-02-12       Impact factor: 3.084

Review 8.  Molecular and therapeutic potential and toxicity of valproic acid.

Authors:  Sébastien Chateauvieux; Franck Morceau; Mario Dicato; Marc Diederich
Journal:  J Biomed Biotechnol       Date:  2010-07-29

9.  Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein.

Authors:  Barbara Monti; Valentina Gatta; Francesca Piretti; Simonetta S Raffaelli; Marco Virgili; Antonio Contestabile
Journal:  Neurotox Res       Date:  2009-07-21       Impact factor: 3.911

10.  Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation.

Authors:  Zoya Marinova; Ming Ren; Jens R Wendland; Yan Leng; Min-Huei Liang; Shigeru Yasuda; Peter Leeds; De-Maw Chuang
Journal:  J Neurochem       Date:  2009-09-18       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.